Valiant Laboratories P/B Ratio

VALIANTLAB • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
1.23
Moderate Valuation
Moderate - Reasonably valued relative to book value

Current Valuation Metrics

P/B Ratio 1.23
Current Price ₹67.19
Book Value/Share ₹53.18
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹234 Cr
Share Capital ₹44 Cr
Reserves & Surplus ₹191 Cr
Outstanding Shares 44,000,000
Book Value per Share ₹53.18

Valuation Signal

Signal Fairly Valued
Historical Avg 2.83
Historical Range 1.32 - 5.26
Percentile 0.0%

Sector Context

Sector Average -0.1
Sector Median 0.66
Sector Rank #11 of 50
Sector Percentile 22.0%

Key P/B Ratio Insights for Valiant Laboratories

  • Current PB is 56.6% below historical average
  • Trading at premium to sector average PB of -0.1

View the current stock price of Valiant Laboratories for more insights.

P/B Ratio Historical Trend for Valiant Laboratories

Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.

Historical P/B Ratio Data

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 1.32 ₹53.18 ₹70.00 ₹234 Moderate
2024 1.92 ₹53.86 ₹103.21 ₹237 Moderate
2023 5.26 ₹30.61 ₹160.86 ₹101 High

Sector P/B Ratio Comparison

Comparing Valiant Laboratories with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -12.97 ₹4,391 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Triochem Products TRIPR 0.04 ₹0 Low
Murae Organisor MURAE 0.26 ₹55 Low